Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

AVI and XTL collaborate on HBV and HCV treatments

Dec. 10, 1999

Pyridazinone cell adhesion inhibitors investigated as promising antiinflammatory agents

Dec. 7, 1999

Adolor studies opioid antagonists for treatment of opiate-induced constipation

Dec. 3, 1999

New 5-HT4 ligands from Kyowa Hakko useful for GI motility disorders

Dec. 2, 1999

NMDA antagonists reported to be useful for IBS

Dec. 1, 1999

DWH-146e and rolipram synergistically block inflammation in murine model of peritonitis

Nov. 30, 1999

Eradication of H. pylori infection obtained with low doses of new cephem

Nov. 26, 1999

Korean investigators disclose new hepatoprotective agents

Nov. 26, 1999

InKine seeks FDA approval of Diacol

Nov. 24, 1999

Agents for ulcers and other GI disorders under study at AstraZeneca

Nov. 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...